CIK: 0001325083 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $140,652 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 5,475,516 | $20,971 | 14.9% | $5.34 | -51.6% | COM | 01438T106 |
| — | Biohaven Pharmactl Hldg Co L | 895,269 | $12,632 | 9.0% | $30.80 | — | COM | G11196105 |
| ENTX | Entera Bio Ltd | 5,881,879 | $11,176 | 7.9% | $2.26 | -12.4% | SHS | M40527109 |
| GLD | SPDR Gold Trust | 32,000 | $9,755 | 6.9% | $205.72 | — | Gold SHS | 78463V107 |
| MGTX | MeiraGTX Holdings | 1,250,000 | $8,150 | 5.8% | $4.32 | +36.6% | COM | G59665102 |
| KGC | Kinross Gold Corp | 440,000 | $6,877 | 4.9% | $4.90 | +196.9% | COM | 496902404 |
| AEM | Agnico Eagle Mines Ltd | 55,500 | $6,601 | 4.7% | $47.02 | +145.0% | COM | 008474108 |
| — | Sandstorm Gold Ltd | 700,000 | $6,580 | 4.7% | $7.55 | — | COM NEW | 80013R206 |
| — | Avadel Pharmaceuticals Plc | 600,000 | $5,310 | 3.8% | $15.45 | — | SPONSORED ADR | 05337M104 |
| ELTX | Elicio Therapeutics Inc | 630,915 | $4,871 | 3.5% | $7.75 | -19.7% | COM | 28657F103 |
| SKE | SKEENA RES LTD CAD | 295,400 | $4,703 | 3.3% | $6.87 | +83.5% | COM | 83056P715 |
| SA | SEABRIDGE GOLD INC | 317,003 | $4,603 | 3.3% | $13.62 | -6.7% | COM | 811916105 |
| ALT | Altimmune Inc | 1,121,524 | $4,340 | 3.1% | $7.72 | -29.9% | COM NEW | 02155H200 |
| FNV | Franco Nev Corp | 25,000 | $4,098 | 2.9% | $108.28 | +52.6% | COM | 351858105 |
| — | Mag Silver Corp | 170,000 | $3,592 | 2.6% | $10.50 | — | COM | 55903Q104 |
| NUVB | Nuvation Bio Inc | 1,025,000 | $2,922 | 2.1% | $2.28 | -8.5% | COM CL A | 67080N101 |
| SLV | iShares Silver Trust | 80,000 | $2,625 | 1.9% | $24.98 | — | iShares | 46428Q109 |
| — | Applied Therapeutics Inc | 7,799,687 | $2,426 | 1.7% | $3.42 | — | COM | 03828A101 |
| OCUL | Ocular Therapeutix Inc. | 600,400 | $1,860 | 1.3% | $6.48 | +20.8% | COM | 67576A100 |
| PM | Philip Morris Intl. Inc | 10,000 | $1,821 | 1.3% | $83.71 | +99.9% | COM | 718172109 |
| V | Visa | 4,850 | $1,722 | 1.2% | $203.18 | +70.8% | COM CL A | 92826C839 |
| RGLD | Royal Gold Inc. | 9,000 | $1,601 | 1.1% | $123.88 | +42.9% | COM | 780287108 |
| ITA | iSHares US Aerospace & Defense | 7,650 | $1,443 | 1.0% | $126.60 | — | US AER DEF ETF | 464288760 |
| BAH | Booz Allen Hamilton HLDG COR | 13,000 | $1,354 | 1.0% | $76.36 | +43.3% | CL A | 099502106 |
| AGI | Alamos Gold Inc | 50,000 | $1,328 | 0.9% | $14.56 | +83.4% | COM CL New | 011532108 |
| WPM | Wheaton Precious Metals Corp | 12,500 | $1,123 | 0.8% | $42.73 | +96.8% | COM | 962879102 |
| NOC | Northrop Grumman Corp | 2,165 | $1,082 | 0.8% | $442.02 | +10.0% | COM | 666807102 |
| CDE | Coeur Mining Inc | 96,132 | $852 | 0.6% | $6.17 | +18.0% | COM NEW | 192108504 |
| MREO | Mereo Biopharma Group | 260,470 | $706 | 0.5% | $2.69 | — | SPON ADS | 589492107 |
| DEO | Diageo PLC | 6,750 | $681 | 0.5% | $148.59 | — | SPONS ADR NEW | 25243Q205 |
| — | Verona Pharma | 7,049 | $667 | 0.5% | $22.97 | — | SPONSORED ADS | 925050106 |
| NEWP | New Pac Metals Corp | 485,000 | $650 | 0.5% | $1.89 | -33.2% | COM | 64782A107 |
| — | HOOKIPA PHARMA | 498,625 | $626 | 0.4% | $0.87 | — | COM | 43906K100 |
| ABEO | Abeona Therapeutics | 62,689 | $356 | 0.3% | $5.69 | 0.0% | COM NEW | 00289Y206 |
| CGAU | Centerra Gold Inc | 1,227,863 | $170 | 0.1% | $6.81 | 0.0% | COM | 152006102 |
| OBIO | Orchestra BioMed Holdings | 455,128 | $170 | 0.1% | $2.92 | 0.0% | COM | 68572M106 |
| CRDL | Cardiol Therapeutics Inc | 100,000 | $136 | 0.1% | $2.12 | -45.1% | COM Cal A | 14161Y200 |
| — | Orgenesis, Inc. | 50,623 | $75 | 0.1% | $6.08 | — | COM | 68619K105 |